Details of the Drug

General Information of Drug (ID: DM1WYDU)

Drug Name
Uridine triacetate
Synonyms PN401
Indication
Disease Entry ICD 11 Status REF
Diabetic complication 5A2Y Approved [1]
Pancreatic cancer 2C10 Approved [1]
Orotic aciduria N.A. Investigative [2]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
Chemical Identifiers
Formula
C15H18N2O9
Canonical SMILES
CC(=O)OCC1C(C(C(O1)N2C=CC(=O)NC2=O)OC(=O)C)OC(=O)C
InChI
1S/C15H18N2O9/c1-7(18)23-6-10-12(24-8(2)19)13(25-9(3)20)14(26-10)17-5-4-11(21)16-15(17)22/h4-5,10,12-14H,6H2,1-3H3,(H,16,21,22)/t10-,12-,13-,14-/m1/s1
InChIKey
AUFUWRKPQLGTGF-FMKGYKFTSA-N
Cross-matching ID
PubChem CID
20058
ChEBI ID
CHEBI:90914
CAS Number
4105-38-8
TTD ID
D0OL7F
Combinatorial Drugs (CBD) Click to Jump to the Detailed CBD Information of This Drug
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

References

1 ClinicalTrials.gov (NCT02110147) Open-Label Study of Uridine Triacetate in Pediatric Patients With Hereditary Orotic Aciduria. U.S. National Institutes of Health.
2 Uridine triacetate FDA Label